Puma Biotechnology Inc (NASDAQ:PBYI)

9.73
Delayed Data
As of Jan 17
 +0.84 / +9.39%
Today’s Change
6.26
Today|||52-Week Range
43.90
+11.20%
Year-to-Date
Is Puma Biotechnology a Buy?
Jan 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close8.90
Today’s open8.95
Day’s range8.90 - 9.86
Volume3,330,283
Average volume (3 months)1,742,814
Market cap$383.0M
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+61.87%
Earnings growth (this year)+30.22%
Earnings growth (next 5 years)+260.25%
Revenue growth (last year)+806.60%
P/E ratioNM
Price/Sales3.08
Price/Book10.98

Competitors

 Today’s
change
Today’s
% change
PRQRProQR Therapeutics N...-0.35-4.17%
EOLSEvolus Inc+0.12+1.07%
SPPISpectrum Pharmaceuti...-0.05-1.52%
REPHRecro Pharma Inc-0.16-1.01%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateFebruary 26, 2020
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$251.0M
Annual profit (last year)-$113.6M
Net profit margin-45.25%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Los Angeles, California

Forecasts